Edition:
India

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

22.84USD
1:27am IST
Change (% chg)

$3.34 (+17.13%)
Prev Close
$19.50
Open
$19.55
Day's High
$23.00
Day's Low
$19.55
Volume
146,772
Avg. Vol
54,543
52-wk High
$23.00
52-wk Low
$4.75

Select another date:

Mon, Nov 14 2016

BRIEF-Zynerba Pharmaceuticals posts Q3 loss per share of $0.67

* Zynerba Pharma - believes available funds sufficient to develop five phase 3 ready programs, sufficient to fund operations & capital requirements into 2018

BRIEF-Zynerba Pharmaceuticals initiates Star 2 open-label extension clinical trial for ZYN002 CBD gel

* Zynerba Pharmaceuticals Inc says enrollment in Star 1 is continuing and plan to report top line results in first half of 2017

BRIEF-Zynerba provides clinical update for lead development candidates - ZYN001 and ZYN002

* Zynerba Pharmaceuticals Inc - topline results for three phase 2 clinical trials for ZYN002 are on track for 1h17

BRIEF-Zynerba reports inducement grant to new chief financial officer

* Zynerba Pharmaceuticals reports inducement grant to new chief financial officer Source text for Eikon: Further company coverage:

BRIEF-Zynerba enters into an open market sale agreement with Jefferies

* Entered into an open market sale agreement with Jefferies Llc, or Jefferies, as placement agent - SEC filing

BRIEF-Zynerba Pharmaceuticals files for mixed shelf of up to $150 mln

* Zynerba Pharmaceuticals Inc files for mixed shelf of up to $150 million -SEC filing Source text (http://bit.ly/2bFPRZ7) Further company coverage:

BRIEF-Zynerba Pharmaceuticals reported Q2 EPS ($0.70)

* Zynerba Pharmaceuticals reports second quarter 2016 financial results and organizational changes

Select another date: